There are currently 204 clinical trials in Tulsa, Oklahoma looking for participants to engage in research studies. Trials are conducted at various facilities, including Oklahoma Cancer Specialists and Research Institute-Tulsa, Natalie Warren Bryant Cancer Center at St. Francis Hospital, GSK Investigational Site and Natalie Warren Bryant Cancer Center at Saint Francis. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Artificial Intelligence to Measure Adherence to Oral Medication
Recruiting
The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.
Gender:
All
Ages:
Between 15 years and 40 years
Trial Updated:
05/24/2023
Locations: Family and Children's Services, Tulsa, Oklahoma
Conditions: First Episode Psychosis
Protect the Head to Head Study
Recruiting
Prospective, randomized, open label, multicenter, 2-arm, safety and efficacy study
Gender:
All
Ages:
18 years and above
Trial Updated:
05/17/2023
Locations: Oklahoma Heart Institute, Tulsa, Oklahoma
Conditions: Embolism
Dyadic Neurofeedback for Development of Healthy Emotion Regulation in Youth
Recruiting
This study will examine the effect of a real-time functional magnetic resonance imaging (fMRI) dyadic neurofeedback protocol with mothers and their adolescent daughters. Mothers in the experimental condition will view a moving bar showing their daughters' brain activity on a computer screen while talking to their daughters.
Gender:
Female
Ages:
14 years and above
Trial Updated:
04/29/2023
Locations: Hardesty Center for Clinical Research and Neuroscience, Tulsa, Oklahoma
Conditions: Emotional Regulation
Approach-Avoidance, Computational Framework for Predicting Behavioral Therapy Outcome (AAC-BeT)
Recruiting
Depression and anxiety disorders rank in the top ten causes of years lived with disability. Less than 50% of patients experiencing long-lasting improvements to current gold-standard treatments. Two gold-standard behavioral interventions include behavioral activation, focused on enhancing approach behavior towards meaningful activities, and exposure-based therapy, focused on decreasing avoidance and challenging negative expectations. While these interventions have divergent treatment targets, the... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/10/2023
Locations: Laureate Institute for Brain Research, Tulsa, Oklahoma
Conditions: Anxiety, Depression
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Recruiting
The purpose of this study is to assess the clinical effectiveness of all approved multiple myeloma (MM) therapies in the newly-diagnosed (NDMM) and the relapsed/refractory MM (RRMM) settings in real-world clinical practice.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/16/2023
Locations: Local Institute, Tulsa, Oklahoma +1 locations
Conditions: Multiple Myeloma
Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)
Recruiting
A Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®) and Standard of Care versus Standard of Care alone in the healing Chronic Diabetic Foot Ulcers. Multi-center, open label, randomized controlled trial. Study is estimated to require 12 months from first subject enrolled to last subject visit.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/03/2022
Locations: Heal Foundation, Tulsa, Oklahoma
Conditions: Chronic Diabetic Foot Ulcers
Unidos Against ATOD Use Intervention Trial
Recruiting
Adolescent alcohol tobacco and drug (ATOD) use is a major public health concern, with rates for Latino middle school youth higher than other ethnic groups. One well-established precursor of adolescent ATOD use is psychosocial stress. The proposed project examines the preliminary efficacy of Unidos to decrease ATOD use among Latino youth in new settlement areas. The goals of this efficacy trial will be achieved by accomplishing two specific aims: (1) Evaluate the potential of the intervention to... Read More
Gender:
All
Ages:
Between 12 years and 17 years
Trial Updated:
07/26/2022
Locations: Oklahoma State University-Tulsa, Tulsa, Oklahoma
Conditions: Substance Use
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata
Recruiting
Efficacy and safety of rosnilimab (ANB030) in subjects with moderate-to-severe Alopecia Areata
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
05/03/2022
Locations: Site 10-106, Tulsa, Oklahoma
Conditions: Alopecia Areata
Interactive Voice Based Administration of the GAD 7
Recruiting
This study investigates a new delivery method for the General Anxiety Disorder - 7 (GAD 7), a clinically accepted tool for diagnosing general anxiety disorder. The new tool records auditory responses to the assessment and the study will examine if the instrument is effective at capturing participant depression levels. If proven effective, future studies may investigate if the new format can be used to improve at home clinical care.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/19/2022
Locations: OSU Behavioral Health Clinic, Tulsa, Oklahoma
Conditions: General Anxiety Disorder
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress
Recruiting
This is a Phase 2 study to assess COVI-MSC in the setting of current standard of care in hospitalized subjects with RT-PCR confirmed SARS-CoV-2 (COVID-19) infection and acute respiratory distress / acute respiratory distress syndrome.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/07/2022
Locations: Ascension St. John, Tulsa, Oklahoma
Conditions: Covid19
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
Recruiting
Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiated registry is to collect information on treatment strategies and outcomes of consecutive patients undergoing CTO PCI among various participating centers. The information collected will be used to deter... Read More
Gender:
All
Ages:
All
Trial Updated:
03/08/2022
Locations: Oklahoma Heart Institute at Hillcrest Medical Center, Tulsa, Oklahoma
Conditions: Coronary Artery Disease
NOVOCART®3D for Treatment of Articular Cartilage of the Knee
Recruiting
This study is to compare NOVOCART 3D relative to Microfracture for the treatment of knee cartilage defects. Efficacy will be evaluated by both pain and function. Safety will also be evaluated.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/01/2022
Locations: Tulsa Bone and Joint Associates, Tulsa, Oklahoma
Conditions: Articular Cartilage of the Femoral Condyle Between 2-6cm2